Search Results - "Manoli, S.M."

Real‐world experience of off‐label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna by Lallas, A., Moscarella, E., Kittler, H., Longo, C., Thomas, L., Zalaudek, I., Kyrgidis, A., Manoli, S.M., Meo, N., Papageorgiou, C., Apalla, Z., Argenziano, G.

“…Because of the tendency of lentigo maligna (LM) for subclinical extension, staged excisions with margin control achieve lower recurrence rates than…”
Get full text

The peculiar dermatoscopic pattern of scalp melanoma by Spyridis, I., Papageorgiou, C., Apalla, Z., Manoli, S.M., Eftychidoy, P., Gkentsidi, T., Bobos, M., Boutis, A., Vakirlis, E., Sotiriou, E., Ioannides, D., Lallas, A.

“…Background Melanomas developing on anatomic sites other than the trunk and extremities have a special pathogenetic and mutational profile, morphologic…”
Get full text

Clinical and dermatoscopic predictors of squamous cell carcinoma of the lips: a case‐control, multicentric study by Lallas, A., Martínez, G., Arceu, M., Kyrgidis, A., Liopyris, K., Brancaccio, G., Longo, C., Errichetti, E., Sgouros, D., Papageorgiou, C., Fotiadou, C., Siskou, S., Manoli, S.M., Sotiriou, E., Ioannides, D., Katoulis, A., Lazaridou, E., Todorovska, V., Argenziano, G., Apalla, Z.

“…Background Squamous cell carcinoma of the lip accounts for 20% of all oral carcinomas. Its diagnosis may be challenging because it clinically resembles actinic…”
Get full text